Identifying and addressing the toxicity of checkpoint inhibitors in lung cancer

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)165-167
Number of pages3
JournalClinical Advances in Hematology and Oncology
Volume14
Issue number3
StatePublished - Mar 1 2016

Fingerprint

CD274 Antigen
Programmed Cell Death 1 Receptor
CTLA-4 Antigen
Molecular Targeted Therapy
Antineoplastic Agents
Immunotherapy
Autoimmune Diseases
Lung Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Identifying and addressing the toxicity of checkpoint inhibitors in lung cancer. / Brahmer, Julie.

In: Clinical Advances in Hematology and Oncology, Vol. 14, No. 3, 01.03.2016, p. 165-167.

Research output: Contribution to journalArticle

@article{3836cb51da0b4f2fac96dcf4db4b8ecd,
title = "Identifying and addressing the toxicity of checkpoint inhibitors in lung cancer",
author = "Julie Brahmer",
year = "2016",
month = "3",
day = "1",
language = "English (US)",
volume = "14",
pages = "165--167",
journal = "Nature Clinical Practice Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Identifying and addressing the toxicity of checkpoint inhibitors in lung cancer

AU - Brahmer, Julie

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84961675247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961675247&partnerID=8YFLogxK

M3 - Article

C2 - 27058029

AN - SCOPUS:84961675247

VL - 14

SP - 165

EP - 167

JO - Nature Clinical Practice Oncology

JF - Nature Clinical Practice Oncology

SN - 1759-4774

IS - 3

ER -